
    
      The aim of this study is to:

        1. Evaluate the clinical outcome of two different dosing regimen of IV colistin in the
           treatment of children with multidrug resistant gram-negative infections or sepsis.

        2. To estimate the frequency of colistin associated adverse effects.

        3. To correlate the serum colistin concentration and MIC to microbiological clearance and
           clinical outcome
    
  